Literature DB >> 33990788

Single-cell atlases dissect tissue destruction by SARS-CoV-2.

Alexandra Flemming1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33990788      PMCID: PMC8121012          DOI: 10.1038/s41577-021-00564-5

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
Severe SARS-CoV-2 infection can cause acute respiratory distress syndrome and multi-organ failure. Now, two studies, published back-to-back in Nature, provide new insights into the pathophysiology of severe COVID-19 at single-cell resolution. Melms et al. carried out single-nucleus RNA sequencing (snRNA-seq) of ~116,000 nuclei from snap-frozen lungs that were collected shortly after death from 19 individuals who died of COVID-19, as well as 7 control lungs. They found that lungs from COVID-19-decedents were highly inflamed and had dense infiltrations of aberrantly activated macrophages. There was evidence of plasma cells capable of producing neutralizing antibodies, but T cell responses appeared to be impaired — indicating that, despite potentially sufficient humoral immune responses, inadequate T cell responses may contribute to lethal COVID-19. Simon Bradbrook/Springer Nature Limited The authors found evidence that SARS-CoV-2 not only directly damages the epithelium but also affects its regeneration. Alveolar type II (AT2) epithelial cells were found to be compromised in their transition to alveolar type I (AT1) cells, with increased numbers of cells arrested at a ‘damage-associated transient progenitor’ (DATP) cell state, which is known to be induced by inflammation. Moreover, fibroblasts were significantly increased, with a rapid expansion of CTHRC1+ pathological fibroblasts, which were recently described as drivers of lung fibrosis. The source of inflammation was further investigated in a mass-cytometry dataset (mRNA analysis is unsuitable for analysing post-translationally activated cytokines), which revealed that myeloid-derived IL-1β distinguishes COVID-19 from other viral or bacterial pneumonias and may contribute to the inflammation-induced impairment of alveolar epithelial regeneration. The second study, by Delorey et al., presents single-cell atlases of 23 lung, 16 kidney, 16 liver and 19 heart autopsy samples from individuals who died of COVID-19. They also describe spatial atlases of 14 SARS-CoV-2-infected lungs, where host responses in regions with and without viral RNA were compared. snRNA-seq of the lungs revealed substantial remodelling in the epithelial, immune and stromal compartments. This included a significant decrease in AT2 cells (possibly due to virus-induced cell death) and an increase in dendritic cells, macrophages, fibroblasts and lymphatic and vascular endothelial cells. Overall, they found widespread cell type-specific transcriptional changes, notably in CD16+ monocytes, lymphatic endothelial, vascular endothelial, AT1 and AT2 cells. They also found an increase of cells with a ‘pre-AT1 transitional cell state’ gene signature, which is similar to the DATP gene signature, and amongst these identified a subset of putative TP63+ intrapulmonary basal-like progenitor cells. These cells had been described in mice infected with H1N1 influenza virus, where they act as an emergency cellular reserve for severely damaged alveoli. This indicates that regenerative strategies are initiated to re-establish alveolar epithelial cells lost to infection, but that a serial failure of epithelial progenitors to regenerate may eventually lead to lung failure. The authors also analysed viral load and associated host responses at single-cell resolution. Viral RNA was mainly detected in mononuclear phagocytes and endothelial cells, but some mast cells, B cells and plasma cells were also SARS-CoV-2-positive. The infected cells had distinct transcriptional programmes compared with uninfected cells. In heart, kidney and liver, only very few viral RNA reads were detected. However, in the heart, both cell composition and gene programmes showed differences compared with healthy hearts, with a significant reduction in the proportion of cardiomyocytes and pericytes and an increase in vascular endothelial cells. The authors also integrated their atlas with genome-wide association studies to identify common variants associated with COVID-19 severity and relate these to particular cell types or tissues. They found several gene loci that linked AT2 cells with severe COVID-19. regenerative strategies are initiated to re-establish alveolar epithelial cells lost to infection, but … a serial failure of epithelial progenitors to regenerate may eventually lead to lung failure The authors of both publications emphasize that their studies are limited by their small sample size. Nevertheless, their work will contribute to a collection of studies with streamlined protocols and harmonized metadata that will provide a critical resource to dissect the pathophysiology of COVID-19.
  2 in total

1.  COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.

Authors:  Toni M Delorey; Carly G K Ziegler; Graham Heimberg; Rachelly Normand; Yiming Yang; Åsa Segerstolpe; Domenic Abbondanza; Stephen J Fleming; Ayshwarya Subramanian; Daniel T Montoro; Karthik A Jagadeesh; Kushal K Dey; Pritha Sen; Michal Slyper; Yered H Pita-Juárez; Devan Phillips; Jana Biermann; Zohar Bloom-Ackermann; Nikolaos Barkas; Andrea Ganna; James Gomez; Johannes C Melms; Igor Katsyv; Erica Normandin; Pourya Naderi; Yury V Popov; Siddharth S Raju; Sebastian Niezen; Linus T-Y Tsai; Katherine J Siddle; Malika Sud; Victoria M Tran; Shamsudheen K Vellarikkal; Yiping Wang; Liat Amir-Zilberstein; Deepak S Atri; Joseph Beechem; Olga R Brook; Jonathan Chen; Prajan Divakar; Phylicia Dorceus; Jesse M Engreitz; Adam Essene; Donna M Fitzgerald; Robin Fropf; Steven Gazal; Joshua Gould; John Grzyb; Tyler Harvey; Jonathan Hecht; Tyler Hether; Judit Jané-Valbuena; Michael Leney-Greene; Hui Ma; Cristin McCabe; Daniel E McLoughlin; Eric M Miller; Christoph Muus; Mari Niemi; Robert Padera; Liuliu Pan; Deepti Pant; Carmel Pe'er; Jenna Pfiffner-Borges; Christopher J Pinto; Jacob Plaisted; Jason Reeves; Marty Ross; Melissa Rudy; Erroll H Rueckert; Michelle Siciliano; Alexander Sturm; Ellen Todres; Avinash Waghray; Sarah Warren; Shuting Zhang; Daniel R Zollinger; Lisa Cosimi; Rajat M Gupta; Nir Hacohen; Hanina Hibshoosh; Winston Hide; Alkes L Price; Jayaraj Rajagopal; Purushothama Rao Tata; Stefan Riedel; Gyongyi Szabo; Timothy L Tickle; Patrick T Ellinor; Deborah Hung; Pardis C Sabeti; Richard Novak; Robert Rogers; Donald E Ingber; Z Gordon Jiang; Dejan Juric; Mehrtash Babadi; Samouil L Farhi; Benjamin Izar; James R Stone; Ioannis S Vlachos; Isaac H Solomon; Orr Ashenberg; Caroline B M Porter; Bo Li; Alex K Shalek; Alexandra-Chloé Villani; Orit Rozenblatt-Rosen; Aviv Regev
Journal:  Nature       Date:  2021-04-29       Impact factor: 69.504

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.